Blueprint Medicines Corp (BPMC)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Aug 13, 16:00
Price Chart
Key Stats
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 2.085 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| N/A |
| URL | http://www.blueprintmedicines.com |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | Jul. 31, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| N/A |
| URL | http://www.blueprintmedicines.com |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | Jul. 31, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |